Zombie Funds in Private Equity: What They Are and How to Protect Yourself as an LP
Private Equity Zombie Funds in Private Equity: What They Are and How to Protect Yourself as an LP By Jeff Barnes, MBA | Angel Investors Network | June 24, 2026 TL;DR: 54% of institutional LPs expec...

Zombie Funds in Private Equity: What They Are and How to Protect Yourself as an LP
TL;DR: 54% of institutional LPs expect the number of zombie funds in their portfolios to grow over the next two years; only 15% expect a decline. $1.16 trillion in private equity assets are currently trapped in aging funds past their prime. GPs collect roughly $20 billion per year in management fees on this stagnant capital. As an LP, you have options — but only if you read the fine print before you sign.
The Warning Sign Hiding in Plain Sight
The Investment News coverage of the Coller Capital Summer 2026 Global Private Capital Barometer put a hard number on something many LPs had been feeling for years. Fifty-four percent of the 108 LPs surveyed, representing $2.045 trillion in combined assets under management, expect zombie fund exposure in their portfolios to increase over the next 24 months. Only 15% expect that count to fall.
That is not a fringe concern. That is the mainstream view from the largest pools of institutional capital on the planet. Pension funds, endowments, family offices, and sovereign wealth vehicles are all bracing for more of the same problem. If you are an accredited investor or LP considering a private equity commitment, this data matters before you sign a limited partnership agreement.
The Coller survey did not arrive in a vacuum. It follows a 38% year-over-year increase in zombie fund assets, which reached $1.16 trillion by the end of 2025. That figure now represents roughly 20% of all global private equity assets. One dollar in five committed to private equity is sitting in a fund that cannot exit its positions and cannot raise a new vehicle.
What a Zombie Fund Actually Is
The term gets used loosely. Here is the precise definition that matters for LPs.
A standard private equity buyout fund runs on a 10-year term. The first five to seven years are the investment period, during which the GP deploys capital into portfolio companies. The remaining years are reserved for managing and exiting those positions. A venture capital fund follows a similar structure, though the timeline typically extends to 12 to 15 years.
A zombie fund is a fund that has passed its investment period, holds remaining portfolio assets, and meets two additional conditions. First, the GP cannot exit those assets at acceptable valuations. Second, the GP has not raised or cannot raise a successor fund, which signals that limited partners have lost confidence in the manager. The fund lingers. Assets sit on the books. The clock does not stop.
Preqin data as of year-end 2025 shows 4,500-plus PE funds globally were 10 or more years old. Of those, approximately 1,200 had made no new investment in three or more years. Those 1,200 funds fit the clinical definition of zombie status.
Average buyout fund liquidation runs about 12 years. Average VC fund liquidation runs about 15 years. Zombie funds regularly persist 15 to 20-plus years. That is a five-to-eight-year extension beyond the expected timeline, and every additional year has a cost that falls on the LP.
To understand why this is a problem for your portfolio returns, see our guide on TVPI and how unrealized gains are reported to LPs.
Why Zombie Funds Form: Three Converging Forces
Zombie funds do not form by accident. Three forces push GPs to keep underperforming vehicles alive.
The fee incentive. Management fees on private equity funds typically run 1.5% to 2.0% per year on net asset value or original cost basis. After the investment period, fees sometimes step down, but they rarely disappear. A GP managing a $500 million zombie fund at 1.75% per year collects $8.75 million annually on assets that are generating no realized returns for LPs. The GP has every financial reason to extend the fund life. The LP has the opposite incentive.
The valuation lag. Private equity assets are not marked to market daily. GPs carry portfolio companies at internally determined valuations, often updated quarterly. In a rising rate environment or a weak exit market, the gap between carrying value and true market value can be substantial. GPs may resist selling at prices that force a formal write-down, because a write-down locks in a loss on paper and damages the GP's performance record for future fundraising. The result: assets sit, valuations stay elevated, and nothing gets sold.
Exit market blockage. IPO windows close. Strategic buyers pull back when financing is expensive. Sponsor-to-sponsor transactions dry up. When there is no liquid exit channel, even a GP who wants to return capital to LPs cannot do so at reasonable prices. The fund becomes a warehouse of illiquid positions with no natural buyer.
All three forces compound. A GP facing a slow exit market, carrying inflated valuations, and collecting comfortable management fees has no urgency to act. The LP bears the cost of inaction.
For context on how this connects to the broader cooling of private credit markets in 2026, read our analysis of the Coller Capital Barometer LP survey findings.
The Math of Fee Drain
The numbers are not abstract. They are transferable wealth moving from LP accounts to GP pockets on stagnant capital.
$1.16 trillion in zombie fund assets. An average management fee of 1.75% per year. The product is approximately $20.3 billion per year flowing from LPs to GPs on funds that are not deploying capital, not exiting positions, and not returning cash.
That is $20 billion per year for managing assets that cannot be managed toward a productive outcome. It does not include carry, which theoretically only gets paid on profits. It does not include fund expenses passed through to LPs: audits, legal fees, portfolio monitoring costs. It is purely the base management fee on $1.16 trillion of trapped capital.
Spread across the approximately 1,200 confirmed zombie funds identified by Preqin, the average GP is collecting around $16.9 million per year in management fees while the LP watches a decade-old investment compound no returns. The incentive asymmetry is structural, not incidental.
For a primer on capital calls and what happens when a fund manager requests additional LP capital, see our overview of capital calls and how to evaluate them.
LP Options When You Are Already Trapped
If you are already in a zombie fund, you are not without recourse. Four paths exist, each with real tradeoffs.
| Option | How It Works | Pro | Con |
|---|---|---|---|
| Secondary Market Sale | Sell your LP interest to a secondary buyer (Lexington, Ardian, Coller Capital, etc.) | Immediate liquidity; clean exit | Typical discount of 15-30% to NAV; you crystallize the loss |
| LP-Led Restructuring | Advisory committee or majority LP vote to restructure fund terms, replace GP, or wind down | Can force resolution without secondary discount; preserves upside | Requires coordinated LP action; slow; GPs resist; often requires supermajority vote |
| GP-Led Continuation Vehicle | GP transfers assets into a new continuation fund; existing LPs choose to exit (usually at secondary pricing) or roll into the new vehicle | Exit option at a negotiated price; allows committed LPs to keep upside | Exit pricing is GP-influenced; LP advisory committee may have conflicts; rollover LPs face new fees on same assets |
| Litigation | Sue for breach of fiduciary duty, LPA violations, or fraudulent valuations | Can recover damages; signals seriousness to GP | Expensive; slow; limited discovery rights under most LPAs; uncertain outcome |
The continuation vehicle option deserves specific attention. The Coller Capital Summer 2026 Barometer found that 40% of LPs expect continuation vehicle activity to grow even if exit market conditions improve. Continuation vehicles were once an emergency tool. They have become a standard product. That normalization changes the negotiating dynamic. GPs now structure continuation vehicles proactively, not as a last resort, which means LP advisory committees need to be alert to pricing terms that favor the GP's new vehicle at the LP's expense.
For more on special purpose vehicles and how similar structures work in venture capital, see our breakdown of SPVs and what LPs should know before joining one.
The Pre-Commitment Checklist: 5 LPA Terms to Negotiate Before You Sign
The most effective zombie fund protection happens before capital is committed. Once you have signed a limited partnership agreement, your rights are fixed. These are the five terms that matter most.
1. Sunset Provision. A sunset provision sets an absolute end date for the fund, regardless of whether remaining assets have been sold. Insist on a hard termination date no more than two years beyond the standard fund life. If the GP cannot exit positions by that date, the fund triggers a mandatory wind-down process. Without a sunset provision, the GP can request annual extensions indefinitely, and most LPAs allow this with a simple majority vote from the advisory committee, which the GP often influences.
2. GP Removal Rights. The LPA should allow LPs holding a defined percentage of capital commitments, typically 66% to 75%, to remove the GP for cause or without cause. Without-cause removal is more powerful and more rare. Many GPs resist it. Push for it anyway. Even if you never exercise this right, its presence in the LPA creates a credible negotiating threat that changes GP behavior.
3. LP-Led Liquidity Windows. Some LPAs now include provisions that require the GP to run a secondary process or establish a defined exit window at specific intervals, typically at years 8, 10, and 12. The GP must obtain third-party pricing and offer LPs the right to exit at that price. This does not guarantee liquidity, but it creates a structured moment of accountability that would otherwise not exist.
4. Zombie Fund Definition Clause. Ask for explicit language defining what constitutes zombie status in your specific fund, with automatic consequences once that threshold is met. A definition might read: if the fund has made no new investment in 24 months, holds no capital reserves for follow-on, and has not returned 80% of committed capital by year 10, the GP must seek LP advisory committee approval for any further extension. Vague language gives GPs interpretive room; specific triggers do not.
5. Management Fee Step-Down. Fees should decline materially after the investment period ends. A reasonable structure drops from 2% during the investment period to 1% or less on remaining NAV post-period. Some LPAs include further step-downs to 0.5% after year 10. The ILPA Principles 3.0 specifically recommends that management fees align with the GP's workload and the actual value-creation activity underway. A GP managing three zombie positions should not earn the same fee rate as one actively deploying capital into new deals. ILPA also recommends that LPs push for quarterly disclosure of any fund that qualifies as aging or non-performing under the fund's own definition.
What to Watch in the Next 12 Months
The exit environment remains the key variable. Interest rates, M&A volume, and IPO windows all affect how quickly zombie funds can clear their positions. The Preqin H1 2026 Fund Manager Outlook shows that sponsors expect deal activity to improve in the second half of 2026, but survey optimism and actual transaction volume have diverged sharply over the past three years.
Watch for two things specifically. First, how GPs price assets in continuation vehicle proposals. If a GP moves assets from a zombie fund into a new continuation vehicle and sets the transfer price at or near current carrying value, LP advisory committee members need to push back hard. That pricing directly determines whether exiting LPs get fair value or subsidize the GP's new vehicle at their own expense.
Second, watch for LP advisory committee conflicts of interest. Some institutions serve on advisory committees of multiple funds managed by the same GP and have existing commitments to the GP's next fund. That alignment can mute the oversight that advisory committees are supposed to provide. Smaller LPs, including accredited investors and family offices, often have no advisory committee seat at all, which makes pre-commitment LPA terms the only real protection available.
The zombie fund problem is structural, not cyclical. The data from Coller Capital and the 1,200-fund count from Preqin both suggest this problem grows with the accumulation of vintage funds from the 2010s and early 2020s. More capital committed means more zombie candidates as those funds age. The LPs who protect themselves are the ones who treat the LPA as a risk document, not a formality.
Disclosure: This article is published by Angel Investors Network for informational purposes only. It does not constitute investment advice, legal advice, or a solicitation to buy or sell any security or fund interest. Jeff Barnes, MBA, is a contributor to Angel Investors Network. Neither the author nor Angel Investors Network holds a position in any fund or security mentioned in this article. Private equity and alternative investments carry significant risk, including the risk of total loss and extended illiquidity. Accredited investors should conduct independent due diligence and consult qualified legal and financial counsel before making any investment decision. Past performance does not guarantee future results.
Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.
Looking for investors?
Browse our directory of 750+ angel investor groups, VCs, and accelerators across the United States.
About the Author
Jeff Barnes, MBA